Robert Orlowski, Florence Maude Thomas Cancer Research Professor at the University of Texas MD Anderson Cancer Center, shared on X:
“Myeloma Paper of the Day:
High prevalence of iron deficiency among daratumumab-treated newly diagnosed myeloma patients; at 1-year, nearly 50% of Dara-IRD-treated patients met the criteria (ferritin <30 mcg/L).”
Title: High prevalence of iron deficiency among daratumumab-treated newly diagnosed multiple myeloma patients
Authors: Y. Lisa Hwa, Dragan Jevremovic, Karen Pak, Prashant Kapoor, Alissa Visram, Morie A. Gertz, David D. Dingli, Francis K. Buadi, Ronald S. Go, Rahma Warsame, Nelson Leung, Wilson I. Gonsalves, Miriam A. Hobbs, Amie L. Fonder, Joselle M. Cook, Moritz Binder, Suzanne R. Hayman, Taxiarchis Kourelis, S. Vincent Rajkumar, Angela Dispenzieri, Shaji K. Kumar, Eli Muchtar
You can read the full article on British Journal of Haematology.
You can find other articles featuring Robert Orlowski on OncoDaily.
